Nizar Jacques Bahlis
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Nizar Jacques Bahlis
Jul 1, 2024, 13:39 |
Blog
Mohamad Mohty: Comprehensive review of Multiple Myeloma published in Nature Reviews Disease Primers
Mohamad Mohty, Head of the clinical hematology and cellular therapy department at Saint-Antoine Hospital, Sorbonne…
Jan 14, 2024, 17:31 |
Insight
Nizar Jacques Bahlis: The most comprehensive AI assisted individualized risk classifier in Multiple Myeloma
Nizar Jacques Bahlis, Associate Professor at the Arnie Charbonneau Cancer Institute, Cumming School of Medicine,…
Oct 3, 2023, 17:43 |
Drugs
,
Insight
Rafael Fonseca: The clinical development curse against venetoclax for t(11;14) multiple myeloma.
Rafael Fonseca, the Chief Innovation Officer at Mayo Clinic, Arizona, recently tweeted on X/Twitter: ''The…
Sep 2, 2023, 00:07 |
Insight
Nizar Jacques Bahlis: Thrilled to share our work Nature Medicine, led by the very talented Holly Lee, with Dr Paola Neri, Francesco Maura, Leo Rasche, Jonathan Keats.
Nizar Jacques Bahlis, associate professor at the Arnie Charbonneau Cancer Institute, Cumming School of Medicine,…
All:
4
Posts:
1 - 100
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Tedros Adhanom Ghebreyesus received University of Nicosia’s Honorary Doctorate
Lisa A. Lacasse: A major milestone towards Congress passing the bipartisan MCED Act
July is Sarcoma Awareness Month
25 Posts You Should Not Miss From ESMOGI24!
Facebook
RSS Feed
Twitter
Linkedin
Youtube